AGTC to Present at Upcoming Gene Therapy Conferences – Nasdaq
|
AGTC to Present at Upcoming Gene Therapy Conferences
Nasdaq 29, 2017 (GLOBE NEWSWIRE) — Applied Genetic Technologies Corporation (NASDAQ:AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare and debilitating … |
